Literature DB >> 32614417

Risk of COVID-19 in Patients With Cancer.

Andrew Robinson1, Bishal Gyawali2, Christopher M Booth1.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32614417     DOI： 10.1001/jamaoncol.2020.2586

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN： 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  4 in total

1.  Clinical Features Associated with COVID-19 Outcome in MM: First Results from International Myeloma Society Dataset.

Authors:  Ajai Chari; Mehmet Kemal Samur; Joaquin Martinez-Lopez; Gordon Cook; Noa Biran; Kwee L Yong; Vania Tietsche de Moraes Hungria; Monika Engelhardt; Francesca Gay; Ana Garcia-Feria; Stefania Oliva; Rimke Oostvogels; Alessandro Gozzetti; Cara A Rosenbaum; Shaji K Kumar; Edward Stadtmauer; Hermann Einsele; Meral Beksac; Katja C Weisel; Kenneth C Anderson; Maria-Victoria Mateos; Philippe Moreau; Jesús San Miguel; Nikhil C Munshi; Hervé Avet-Loiseau
Journal:  Blood       Date:  2020-11-06       Impact factor: 22.113

2.  Infection and reinfection with SARS-CoV-2 in cancer patients: A cohort study.

Authors:  Cornelia Nitipir; Andreea Ioana Parosanu; Mihaela Olaru; Ana Maria Popa; Cristina Pirlog; Cristian Iaciu; Radu Vrabie; Miruna Ioana Stanciu; Anca Oprescu-Macovei; Dragos Bumbacea; Carolina Negrei; Cristina Orlov-Slavu
Journal:  Exp Ther Med       Date:  2022-04-15       Impact factor: 2.751

3.  Immunotherapy or other anti-cancer treatments and risk of exacerbation and mortality in cancer patients with COVID-19: a systematic review and meta-analysis.

Authors:  Bolin Wang; Yan Huang
Journal:  Oncoimmunology       Date:  2020-09-22       Impact factor: 8.110

4.  Oncology patients' perceptions of and experiences with COVID-19.

Authors:  Christine Miaskowski; Steven M Paul; Karin Snowberg; Maura Abbott; Hala Borno; Susan Chang; Lee May Chen; Bevin Cohen; Bruce A Cooper; Marilyn J Hammer; Stacey A Kenfield; Angela Laffan; Jon D Levine; Rachel Pozzar; Katy K Tsai; Erin L Van Blarigan; Katherine Van Loon
Journal:  Support Care Cancer       Date:  2020-08-18       Impact factor: 3.359
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.